S'abonner

Pattern recognition receptor-mediated cytokine response in infants across 4 continents? - 01/03/14

Doi : 10.1016/j.jaci.2013.09.038 
Kinga K. Smolen, MSc a, Candice E. Ruck, BSc a, Edgardo S. Fortuno, PhD b, Kevin Ho, BSc b, Pedro Dimitriu, PhD c, William W. Mohn, PhD c, David P. Speert, MD b, c, Philip J. Cooper, MBBS, PhD d, e, f, , Monika Esser, MD g, , Tessa Goetghebuer, MD h, , Arnaud Marchant, MD, PhD i, , Tobias R. Kollmann, MD, PhD a, b,
a Department of Experimental Medicine, University of British Columbia, Vancouver, British Columbia, Canada 
b Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada 
c Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada 
d Centro de Investigaciones FEPIS, Esmeraldas, Quininde, Ecuador 
e Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom 
f Centro de Investgación en Enfermedades Infecciosas, Escuela de Biología, Pontificia Universidad Católica del Ecuador, Casilla, Quito, Ecuador 
g Immunology Unit, Division of Medical Microbiology, Department of Pathology, NHLS and Stellenbosch University, Matieland, South Africa 
h Department of Paediatrics, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium 
i Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium 

Corresponding author: Tobias R. Kollmann, MD, PhD, CFRI A5-147, 950 W28th Ave, Vancouver, BC, Canada V5Z 4H4.

Abstract

Background

Susceptibility to infection as well as response to vaccination varies among populations. To date, the underlying mechanisms responsible for these clinical observations have not been fully delineated. Because innate immunity instructs adaptive immunity, we hypothesized that differences between populations in innate immune responses may represent a mechanistic link to variation in susceptibility to infection or response to vaccination.

Objective

Determine whether differences in innate immune responses exist among infants from different continents of the world.

Methods

We determined the innate cytokine response following pattern recognition receptor (PRR) stimulation of whole blood from 2-year-old infants across 4 continents (Africa, North America, South America, and Europe).

Results

We found that despite the many possible genetic and environmental exposure differences in infants across 4 continents, innate cytokine responses were similar for infants from North America, South America, and Europe. However, cells from South African infants secreted significantly lower levels of cytokines than did cells from infants from the 3 other sites, and did so following stimulation of extracellular and endosomal but not cytosolic PRRs.

Conclusions

Substantial differences in innate cytokine responses to PRR stimulation exist among different populations of infants that could not have been predicted. Delineating the underlying mechanism(s) for these differences will not only aid in improving vaccine-mediated protection but possibly also provide clues for the susceptibility to infection in different regions of the world.

Le texte complet de cet article est disponible en PDF.

Key words : Innate immunity, immune development, infectious disease, global

Abbreviations used : LPS, MDP, NOD, PCA, PGN, Poly I:C, PRR, R848, TLR


Plan


 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 T.R.K. is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and a Michael Smith Foundation for Health Research Career Investigator Award. D.P.S. is a Sauder Family Professor of Pediatric Infectious Diseases. P.J.C is supported by the Wellcome Trust (088862/Z/09/Z). A.M. is a senior research associate at the Belgian Fund for Scientific Research. This work was in part supported by the BC Children’s Hospital (BCCH) Foundation and CIHR CMF-108029.
 Disclosure of potential conflict of interest: E. S. Fortuno has received research support from the Burroughs Wellcome Fund (BWF). W .W. Mohn has received research support from the Canadian Institutes of Health Research and the Tula Foundation. P. J. Cooper has received research support from the Wellcome Trust. M. Esser is employed by the National Health Laboratory Systems. A. Marchant has received research support from GSK Biologicals, has received consultancy fees from GSK Biologicals and Hookipa, and is employed by ImmuneHealth. T. R. Kollmann has received research support from the BCCH Foundation, Canadian Institutes of Health Research (CIHR), Department of Defense (DOD), National Institutes of Health, and ADVAXIS, Inc, and has received travel support from the BCCH Foundation. The rest of the authors claim that they have no relevant conflicts of interest.


© 2013  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 133 - N° 3

P. 818 - mars 2014 Retour au numéro
Article précédent Article précédent
  • Fatal combined immunodeficiency associated with heterozygous mutation in STAT1
  • Nigel Sharfe, Amit Nahum, Andrea Newell, Harjit Dadi, Bo Ngan, Sergio L. Pereira, Jo-Anne Herbrick, Chaim M. Roifman
| Article suivant Article suivant
  • Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation?
  • Nazanin Farhadi, Laura Lambert, Chiara Triulzi, Peter J.M. Openshaw, Nadia Guerra, Fiona J. Culley

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.